This inventor holds 1 USPTO granted patent. Top assignee: Lutana Gmbh. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Stefan Kiesgen
Introduction
Stefan Kiesgen is a notable inventor based in Munich, Germany. He has made significant contributions to the field of molecular delivery systems. His work focuses on innovative constructs that enhance the delivery of therapeutic molecules into cells.
Latest Patents
Stefan Kiesgen holds a patent for a construct designed for the delivery of a molecule into the cytoplasm of a cell. This patent describes a construct that includes a targeting moiety, a fusogenic moiety derived from dengue virus glycoprotein E, and a molecule intended for delivery. The patent also outlines a pharmaceutical composition that includes this construct and a pharmaceutical acceptable carrier. Additionally, it describes a kit that contains fusogenic sequences for effective delivery of various therapeutic agents.
Career Highlights
Stefan Kiesgen is associated with Lutana GmbH, where he continues to develop innovative solutions in the field of molecular biology. His work has the potential to impact therapeutic delivery systems significantly.
Collaborations
Stefan collaborates with talented individuals such as Michaela Arndt and Jürgen Krauss, contributing to a dynamic research environment.
Conclusion
Stefan Kiesgen's innovative work in molecular delivery systems exemplifies the importance of advancements in biotechnology. His contributions are paving the way for more effective therapeutic interventions.